<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37832655</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7492</ISSN><JournalIssue CitedMedium="Internet"><Volume>338</Volume><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Virus research</Title><ISOAbbreviation>Virus Res</ISOAbbreviation></Journal><ArticleTitle>HMGB1 Release Induced by EV71 Infection Exacerbates Blood-Brain Barrier Disruption via VE-cadherin Phosphorylation.</ArticleTitle><Pagination><StartPage>199240</StartPage><MedlinePgn>199240</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">199240</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2023.199240</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0168-1702(23)00202-2</ELocationID><Abstract><AbstractText Label="PURPOSE">EV71 (Enterovirus 71) is a major causative agent of the outbreaks of HFMD (hand, foot, and mouth disease), which is associated with neurological damage caused by permeability disruption of BBB (blood-brain barrier). HMGB1 (high-mobility group box 1) is a widely expressed nuclear protein that triggers host inflammatory responses. Our work aimed to explore the function of HMGB1 in EV71 infection and its contributions to EV71-related BBB damage.</AbstractText><AbstractText Label="METHODS">HeLa cells, HT-29 cells and AG6 mice were used to explore the translocation of HMGB1 in EV71 infection in vitro and in vivo. The roles of released HMGB1 on EV71 replication and associated inflammatory cytokines were investigated using recombinant HMGB1 in HeLa cells. The mechanisms of released HMGB1 in EV71-induced BBB injury were explored using recombinant HMGB1 and anti-HMGB1 neutralizing antibodies in monolayer HCMECs (immortalized human brain microvascular endothelial cells) and AG6 mice brain.</AbstractText><AbstractText Label="RESULTS">EV71 induced HMGB1 nucleocytoplasmic translocation and extracellular release in vitro and in vivo. Released HMGB1 acted as an inflammatory mediator in EV71 infection rather than affecting viral replication in vitro. Released HMGB1 disrupted BBB integrity by enhancing VE-cadherin phosphorylation at tyrosine 685 in HCMECs, and reducing total VE-cadherin levels in HCMECs and AG6 mice in EV71 infection. And released HMGB1 induced an increase in activated astrocytes. Neutralization of HMGB1 reversed the increased endothelial hyperpermeability and phosphorylation of VE-cadherin in HCMECs.</AbstractText><AbstractText Label="CONCLUSION">The inflammatory mediator HMGB1 released by EV71 exacerbated BBB disruption by enhancing VE-cadherin phosphorylation, which in turn aggravated EV71-induced neuroinflammation.</AbstractText><CopyrightInformation>Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>You</LastName><ForeName>Qiao</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>China Department of Ophthalmology, Tianjin First Central Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Burn and Plastic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Yurong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Ningxia University, Yinchuan, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Enhui</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Child Healthcare, Wenzhou People's Hospital, Wenzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Ruining</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School of Nanjing University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Deyan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Public Health Research, Medical School of Nanjing University, Nanjing, China. Electronic address: chendeyan@nju.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Ningxia University, Yinchuan, PR China; State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, China; Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, China. Electronic address: wzhw@nju.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virus Res</MedlineTA><NlmUniqueID>8410979</NlmUniqueID><ISSNLinking>0168-1702</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C094954">cadherin 5</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="Y">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024243" MajorTopicYN="Y">HMGB1 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BBB</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">HMGB1</Keyword><Keyword MajorTopicYN="N">VE-cadherin phosphorylation</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>14</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>13</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37832655</ArticleId><ArticleId IdType="pmc">PMC10587765</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2023.199240</ArticleId><ArticleId IdType="pii">S0168-1702(23)00202-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Andersson U, Ottestad W, Tracey KJ. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19? Mol Med. 2020;26(1):42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7203545</ArticleId><ArticleId IdType="pubmed">32380958</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139–162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4536551</ArticleId><ArticleId IdType="pubmed">21219181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007;356(12):1226–1234.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D, Feng C, Tian X, Zheng N, Wu Z. Promyelocytic Leukemia Restricts Enterovirus 71 Replication by Inhibiting Autophagy. Front Immunol. 2018;9:1268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5996053</ArticleId><ArticleId IdType="pubmed">29922292</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo E, Farina C. Astrocytes: Key Regulators of Neuroinflammation. Trends Immunol. 2016;37(9):608–620.</Citation><ArticleIdList><ArticleId IdType="pubmed">27443914</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017;35:441–468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8167938</ArticleId><ArticleId IdType="pubmed">28226226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B, Levent F. Hand, Foot, and Mouth Disease. JAMA. 2018;320(23):2492. -2492.</Citation><ArticleIdList><ArticleId IdType="pubmed">30561482</ArticleId></ArticleIdList></Reference><Reference><Citation>Crabol Y, Pean P, Mey C, et al. A prospective, comparative study of severe neurological and uncomplicated hand, foot and mouth forms of paediatric enterovirus 71 infections. Int J Infect Dis. 2017;59:69–76.</Citation><ArticleIdList><ArticleId IdType="pubmed">28438677</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejana E, Orsenigo F. Endothelial adherens junctions at a glance. J Cell Sci. 2013;126(Pt 12):2545–2549.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781019</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng C, Zhao L, Yang Z, et al. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol Sin. 2022;43(3):520–528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888646</ArticleId><ArticleId IdType="pubmed">34040166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X, Li S, Zhu L. Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases. Cytokine Growth Factor Rev. 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">34503914</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng C, Fu Y, Chen D, et al. miR-127-5p negatively regulates enterovirus 71 replication by directly targeting SCARB2. FEBS Open Bio. 2017;7(6):747–758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5458453</ArticleId><ArticleId IdType="pubmed">28593131</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol. 2014;88(6):3369–3378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y, Zhang L, Zhang R, et al. Enterovirus 71 Suppresses miR-17-92 Cluster Through Up-Regulating Methylation of the miRNA Promoter. Front Microbiol. 2019;10:625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6447709</ArticleId><ArticleId IdType="pubmed">30984146</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaikwad S, Puangmalai N, Bittar A, et al. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer's disease and frontotemporal dementia. Cell Rep. 2021;36(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341760</ArticleId><ArticleId IdType="pubmed">34289368</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Sun T, Zhou G, et al. Pathogenesis Study of Enterovirus 71 Using a Novel Human SCARB2 Knock-In Mouse Model. mSphere. 2021;6(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546711</ArticleId><ArticleId IdType="pubmed">33692197</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JH, Park JH, Jee MH, et al. Hepatitis C virus infection is blocked by HMGB1 released from virus-infected cells. J Virol. 2011;85(18):9359–9368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165778</ArticleId><ArticleId IdType="pubmed">21752923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagele D, Rossetto CC, Tarrant MT, Pari GS. Analysis of the interactions of viral and cellular factors with human cytomegalovirus lytic origin of replication, oriLyt. Virology. 2012;424(2):106–114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3288578</ArticleId><ArticleId IdType="pubmed">22236369</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13(4):379–393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3647473</ArticleId><ArticleId IdType="pubmed">23601101</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Chen Z, Chin I, Chen Z, Dai H. The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions. Curr Neuropharmacol. 2018;16(9):1375–1384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251046</ArticleId><ArticleId IdType="pubmed">29473514</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135(3):311–336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6781630</ArticleId><ArticleId IdType="pubmed">29411111</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnerbauer M, Wheeler MA, Quintana FJ. Astrocyte Crosstalk in CNS Inflammation. Neuron. 2020;108(4):608–622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7704785</ArticleId><ArticleId IdType="pubmed">32898475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol. 2012;86(7):3767–3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Min HJ, Kim JH, Yoo JE, et al. ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition. Mucosal Immunol. 2017;10(3):685–694.</Citation><ArticleIdList><ArticleId IdType="pubmed">27624778</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisy D, Avilov SV, Jacob Y, et al. HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication. J Virol. 2012;86(17):9122–9133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3416134</ArticleId><ArticleId IdType="pubmed">22696656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TT, Chiu CH, Lin CY, et al. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2022;399(10336):1708–1717.</Citation><ArticleIdList><ArticleId IdType="pubmed">35427481</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishibori M, Mori S, Takahashi HK. Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases. J Pharmacol Sci. 2019;140(1):94–101.</Citation><ArticleIdList><ArticleId IdType="pubmed">31105025</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishibori M, Wang D, Ousaka D, Wake H. High Mobility Group Box-1 and Blood-Brain Barrier Disruption. Cells. 2020;9(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764171</ArticleId><ArticleId IdType="pubmed">33321691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosaka N, Hatayama K, Yamada M, et al. Anti-high mobility group box-1 monoclonal antibody treatment of brain edema induced by influenza infection and lipopolysaccharide. J Med Virol. 2018;90(7):1192–1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">29573352</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19(12):1584–1596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4080800</ArticleId><ArticleId IdType="pubmed">24309662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. The Lancet Neurology. 2010;9(11):1097–1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsenigo F, Giampietro C, Ferrari A, et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun. 2012;3:1208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514492</ArticleId><ArticleId IdType="pubmed">23169049</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y, Zhan Y, Yang S, et al. Newcastle disease virus infection triggers HMGB1 release to promote the inflammatory response. Virology. 2018;525:19–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">30216776</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu S, Kouzaki H, Kato T, Tojima I, Shimizu T. HMGB1-TLR4 signaling contributes to the secretion of interleukin 6 and interleukin 8 by nasal epithelial cells. Am J Rhinol Allergy. 2016;30(3):167–172.</Citation><ArticleIdList><ArticleId IdType="pubmed">27216346</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. The Lancet Infectious Diseases. 2010;10(11):778–790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta. 2010;1799(1-2):101–113.</Citation><ArticleIdList><ArticleId IdType="pubmed">20123072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Li N, Zhang J, et al. Enolase of Streptococcus Suis Serotype 2 Enhances Blood-Brain Barrier Permeability by Inducing IL-8 Release. Inflammation. 2016;39(2):718–726.</Citation><ArticleIdList><ArticleId IdType="pubmed">26732390</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133–150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-Brain Barrier: From Physiology to Disease and Back. Physiol Rev. 2019;99(1):21–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6335099</ArticleId><ArticleId IdType="pubmed">30280653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Liu K, Wake H, Teshigawara K, Mori S, Nishibori M. Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats. Sci Rep. 2017;7:46243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5385548</ArticleId><ArticleId IdType="pubmed">28393932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Ji S, Wang M, et al. HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway. Eur J Pharmacol. 2020;880</Citation><ArticleIdList><ArticleId IdType="pubmed">32417325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248–251.</Citation><ArticleIdList><ArticleId IdType="pubmed">10398600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yuan M, Wang S, et al. STAT3 Regulates the Type I IFN-Mediated Antiviral Response by Interfering with the Nuclear Entry of STAT1. Int J Mol Sci. 2019;20(19)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6801597</ArticleId><ArticleId IdType="pubmed">31575039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Yuan M, Yang E, Chen D, Su A, Wu Z. Enterovirus 71 infection induced Aquaporin-4 depolarization by increasing matrix metalloproteinase-9 activity. Neurosci Lett. 2021;759</Citation><ArticleIdList><ArticleId IdType="pubmed">34126180</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KT, Munisamy B, Ong KC, et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. 2008;67(2):162–169.</Citation><ArticleIdList><ArticleId IdType="pubmed">18219253</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Jiang N, Nawaz W, et al. Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome. PLoS Pathog. 2021;17(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8139491</ArticleId><ArticleId IdType="pubmed">33974679</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue J, Suarez JS, Minaai M, et al. HMGB1 as a therapeutic target in disease. J Cell Physiol. 2021;236(5):3406–3419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8104204</ArticleId><ArticleId IdType="pubmed">33107103</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu R, Yang D, Lei S, et al. HMGB1 Promotes Hepatitis C Virus Replication by Interaction with Stem-Loop 4 in the Viral 5′ Untranslated Region. J Virol. 2015;90(5):2332–2344.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810710</ArticleId><ArticleId IdType="pubmed">26656705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zha C, Meng X, Li L, et al. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis. Cancer Biol Med. 2020;17(1):154–168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7142852</ArticleId><ArticleId IdType="pubmed">32296583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Takahashi HK, Liu K, et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke. 2011;42(5):1420–1428.</Citation><ArticleIdList><ArticleId IdType="pubmed">21474801</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 2015;163(5):1064–1078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655822</ArticleId><ArticleId IdType="pubmed">26590417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W, Shi H, Chen Y, Xu Z, Chen J, Jin L. Alteration of serum high-mobility group protein 1 (HMGB1) levels in children with enterovirus 71-induced hand, foot, and mouth disease. Medicine (Baltimore) 2017;96(17):e6764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5413272</ArticleId><ArticleId IdType="pubmed">28445307</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Guan MY, Li RT, et al. Zika virus leads to olfactory disorders in mice by targeting olfactory ensheathing cells. EBioMedicine. 2023;89</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931927</ArticleId><ArticleId IdType="pubmed">36739631</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818–828.</Citation><ArticleIdList><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Hu S, Li Y, et al. Interleukins and Ischemic Stroke. Front Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8841354</ArticleId><ArticleId IdType="pubmed">35173738</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>